Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Egalet Corp (NASDAQ:EGLT)

5.34
Delayed Data
As of 4:00pm ET
 -0.56 / -9.49%
Today’s Change
4.34
Today|||52-Week Range
10.00
-30.20%
Year-to-Date
Here's Why Egalet Corp. Stock Fell 20% Today
Jan 10 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close5.90
Today’s open5.74
Day’s range5.28 - 5.84
Volume1,153,950
Average volume (3 months)739,575
Market cap$148.6M
Dividend yield--
Data as of 4:00pm ET, 01/17/2017

Growth & Valuation

Earnings growth (last year)+1.01%
Earnings growth (this year)-25.43%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,089.06%
P/E ratioNM
Price/Sales9.53
Price/Book1.66

Competitors

 Today’s
change
Today’s
% change
XENEXenon Pharmaceutical...-0.15-1.80%
NYMXNymox Pharmaceutical...+0.10+3.33%
SNDXSyndax Pharmaceutica...-0.11-1.40%
REPHRecro Pharma Inc-0.40-5.33%
Data as of 4:00pm ET, 01/17/2017

Financials

Next reporting dateMarch 14, 2017
EPS forecast (this quarter)-$0.92
Annual revenue (last year)$22.8M
Annual profit (last year)-$57.9M
Net profit margin-253.76%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Robert Samuel Radie
Chief Operating Officer &
Executive VP
Mark Strobeck
Corporate headquarters
Wayne, Pennsylvania

Forecasts


Search for Jobs